Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario

Background: First-line treatment of epithelial ovarian cancer (EOC) consists of a combination of cytoreductive surgery and platinum-based chemotherapy. Recently, targeted therapies such as bevacizumab have been shown to improve oncologic outcomes in a subset of a high-risk population. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiru L., Chan, Wing C., Bouchard-Fortier, Geneviève, Lheureux, Stephanie, Ferguson, Sarah E., Krzyzanowska, Monika K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406672/
https://www.ncbi.nlm.nih.gov/pubmed/36005210
http://dx.doi.org/10.3390/curroncol29080472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406672/
https://www.ncbi.nlm.nih.gov/pubmed/36005210
http://dx.doi.org/10.3390/curroncol29080472

Ejemplares similares